Search alternatives:
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
61
-
62
Demographics of the study population.
Published 2024“…In the comparison among the ipsilateral, contralateral side of iPD with clinical laterality, and disease control group, the OBH of the disease control group was significantly larger than both the ipsilateral and contralateral sides (<i>P</i> < 0.05). …”
-
63
Table 3 -
Published 2024“…In the comparison among the ipsilateral, contralateral side of iPD with clinical laterality, and disease control group, the OBH of the disease control group was significantly larger than both the ipsilateral and contralateral sides (<i>P</i> < 0.05). …”
-
64
Flow chart showing the exclusion criteria.
Published 2024“…Despite having jobs with higher level of PA and participating in more moderate-to-vigorous PA, a larger proportion of Hispanics participants had NAFLD and significant fibrosis.…”
-
65
-
66
DataSheet1_Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole.docx
Published 2021“…The mutation of CYP3A5 has no significant effect. Furthermore, CYP2C19*17 mutants could strengthen the effects of glucocorticoids and decrease VRC C<sub>min</sub>/dose to a larger extent.…”
-
67
-
68
-
69
-
70
-
71
-
72
Data Sheet 1_Exploring long COVID in pediatric patients: clinical insights from a long COVID clinic.docx
Published 2025“…</p>Methods<p>We conducted a retrospective study of patients aged 0–21 years evaluated at the Long COVID Clinic at Children's Hospital Los Angeles between August 2021 and November 2023. …”
-
73
Data extracted from the included studies.
Published 2024“…Three studies reported an increase in the proportion of patients admitted after introducing an ADP, one of which was significant while 15 studies reported a significant decrease in admission proportion. …”
-
74
Risk of bias assessments for controlled trials.
Published 2024“…Three studies reported an increase in the proportion of patients admitted after introducing an ADP, one of which was significant while 15 studies reported a significant decrease in admission proportion. …”
-
75
S2 File -
Published 2023“…The dogs in this study were part of a larger clinical trial evaluating the use of combinations of doxorubicin chemotherapy, anti-CD20 monoclonal antibody, and one of three small molecule inhibitors: KPT-9274, TAK-981, or RV1001. …”
-
76
Treatment protocols for arms in current study.
Published 2023“…The dogs in this study were part of a larger clinical trial evaluating the use of combinations of doxorubicin chemotherapy, anti-CD20 monoclonal antibody, and one of three small molecule inhibitors: KPT-9274, TAK-981, or RV1001. …”
-
77
S1 File -
Published 2023“…The dogs in this study were part of a larger clinical trial evaluating the use of combinations of doxorubicin chemotherapy, anti-CD20 monoclonal antibody, and one of three small molecule inhibitors: KPT-9274, TAK-981, or RV1001. …”
-
78
Characteristics of the study participants.
Published 2025“…A significant time effect was also observed for PPT, with an increase in the right-side threshold (p = 0.0186; d = 0.58). …”
-
79
Table_1_Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey.DOCX
Published 2022“…Findings of similar bioavailability for both CBD and THC after galenic oil compared with oromucosal spray dosing may be clinically relevant and deserve additional research in larger cohorts.…”
-
80
Table_1_Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey.DOCX
Published 2022“…Findings of similar bioavailability for both CBD and THC after galenic oil compared with oromucosal spray dosing may be clinically relevant and deserve additional research in larger cohorts.…”